RxDoctor Payments Data

Emily Spangler

Women's Health · Lakeland, FLNPI 1174026884

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 65 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 37.8% of the total.

$1,390in general payments, 2019–2025

Across 65 payments — averaging $21.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$526
  • Pfizer$131
  • Astellas Pharma US Inc$124
  • Sumitomo Pharma America, Inc.$94
  • Mayne Pharma Commercial LLC$71
  • Bayer$61
  • plus $382 from 13 others

What the payments were for

  • Food & beverage$1,390100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,390 in reported general payments places this provider in the 80th percentile of 308 women's health providers in Florida.

See all women's health providers in Florida

Medicare billing

Part B allowed, 2024
$1,378
Medicare patients
13
Services billed
25

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol52$3,282
ProgesteroneProgesterone, Micronized30$1,732
Estradiol (Once Weekly)Estradiol17$874

Paid to pharmacies, not to this prescriber.

Other women's health in Lakeland

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →